Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
2017-11-22
Target enrollment:
Participant gender:
Summary
Oral Mucositis (OM) is a painful and debilitating side effect of many of the drug/radiation
regimens used to treat cancer. This study examines the investigational drug brilacidin and
its possible application in prevention of oral mucositis in patients undergoing
chemoradiation for treatment of head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Cellceutix Corporation Innovation Pharmaceuticals, Inc.